Click here to request a free copy of the executive summary of
this report.

The Market for Neurotechnology
2010-2014
350 pages
Published: May 2009

This newly published market research report is the most comprehensive and up-to-date publication available covering the neurotechnology industry. The report takes an in-depth look at the technology, markets, competitors, and growth rates in four key segments of the neurotechnology industry in the years 2010 through 2014. It forecasts the number of systems to be sold, worldwide revenue, compound annual growth rates, and competitor market shares for several key product categories making up the neural prostheses, neuromodulation, neurorehabilitation, and neurosensing segments of the industry.

The Market for Neurotechnology: 2010-2014 covers in detail all the key public companies and the most significant emerging and more established non-public firms in the industry. The report also features in-depth profiles of major research institutions in the U.S. and abroad involved with neurotechnology developments, and traces the commercial activity that is emerging from each.

The report not only looks at future financial projections, it covers likely technology trends and product developments that will impact the neurotechnology industry in the years ahead, such as:

• Nanowire brain implants guided into position through the cerebral vasculature.
• Optical stimulation devices that solve many of the problems associated with electrical charge buildup.
• Microfluidic interfaces that combine electrical stimulation and drug delivery.

The Market for Neurotechnology: 2010-2014 examines each of the neurological diseases and disorders that represent a significant market potential for neurotechnology products, including established markets like Parkinson’s disease, chronic pain, and urinary incontinence, as well as emerging markets such as tinnitus, vestibular disorders, obesity, migraine, sleep disorders, and affective disorders. And it is the only report on the neurotechnology industry to forecast new product categories in neurorehabilitation and neurosensing such as brain analysis systems and neurorobotic systems.